Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-07-022256
Filing Date
2007-03-26
Accepted
2007-03-26 14:06:31
Documents
6
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a07-8838_110k.htm 10-K 1719709
2 EX-23.1.1 a07-8838_1ex23d1d1.htm EX-23.1.1 2057
3 EX-31.1.1 a07-8838_1ex31d1d1.htm EX-31.1.1 9727
4 EX-31.2.1 a07-8838_1ex31d2d1.htm EX-31.2.1 9723
5 EX-32.1.1 a07-8838_1ex32d1d1.htm EX-32.1.1 7360
6 GRAPHIC g88381dsi001.gif GRAPHIC 11079
  Complete submission text file 0001104659-07-022256.txt   1765408
Mailing Address 2001 ALICEANNA STREET BALTIMORE MD 21231-3043
Business Address 2001 ALICEANNA STREET BALTIMORE MD 21231-3043 410-522-5005
OSIRIS THERAPEUTICS, INC. (Filer) CIK: 0001360886 (see all company filings)

EIN.: 710881115 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32966 | Film No.: 07717554
SIC: 2836 Biological Products, (No Diagnostic Substances)